JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported revenue was THB 102.5 million compared to THB 113.78 million a year ago. Net loss was THB 11.85 million compared to net income of THB 11.89 million a year ago. Basic loss per share from continuing operations was THB 0.02 compared to basic earnings per share from continuing operations of THB 0.03 a year ago.
For the six months, revenue was THB 187.97 million compared to THB 209.54 million a year ago. Net loss was THB 23.44 million compared to net income of THB 19.37 million a year ago. Basic loss per share from continuing operations was THB 0.05 compared to basic earnings per share from continuing operations of THB 0.06 a year ago.